Clinical Trial Update: Efficacy and Safety Study of Tesamorelin in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Muscle Wasting [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tesamorelin for muscle wasting in COPD was terminated; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Tesamorelin (tesamorelin)

Snippet

Sponsor: Theratechnologies | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Status: TERMINATED | Results posted: 2014-05-07